You have 9 free searches left this month | for more free features.

City

Beijing (2)

Shanghai (1)

Condition

Advanced Malignant Solid Tumors (1)

Advanced Urothelial Carcinoma (1)

Solid Tumors (1)

Overall Status

Recruiting (2)

Not yet recruiting (1)

Sign in for free

Phase

phase 1/phase 2 (2)

phase 1 (1)

Sponsor

Mabwell (Shanghai) Bioscience Co., Ltd. (3)

Collaborator

Intervention

9mw2821 (3)

toripalimab (1)

Study Documents

Intervention Type

drug (3)

Funder Type

Industry (3)

Study Type

Interventional (3)

9mw2821

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Advanced Urothelial Carcinoma Trial in Beijing (9MW2821, Toripalimab)

Not yet recruiting

Advanced Urothelial Carcinoma

9MW2821
Toripalimab

Beijing, Beijing, China

Beijing Cancer Hospital

Oct 9, 2023

Advanced Malignant Solid Tumors Trial in Beijing (9MW2821)

Recruiting

Advanced Malignant Solid Tumors

9MW2821

Beijing, Beijing, China
+1 more

Mar 6, 2023

Solid Tumors Trial in Shanghai (9MW2821)

Recruiting

Solid Tumors

9MW2821

Shanghai, Shanghai, China

Fudan University Shanghai Cancer Center

Jun 14, 2022